Ignite Creation Date:
2024-05-06 @ 6:57 PM
Last Modification Date:
2024-10-26 @ 2:57 PM
Study NCT ID:
NCT05841420
Status:
RECRUITING
Last Update Posted:
2023-07-27
First Post:
2023-03-16
Brief Title:
Gemcitabine Versus Reduced-dose Combination Chemotherapy in Fragile Patients With Non-resectable Pancreatic Cancer
Sponsor:
Morten Ladekarl
Organization:
Aalborg University Hospital
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-12
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2023-03-16
First Submit QC Date:
May 1 2023
Study First Post Date:
2023-05-03
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-25
Last Update Post Date:
2023-07-27
Last Update Post Date Type:
ACTUAL